Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 07  •  04:00PM ET
284.86
Dollar change
+2.59
Percentage change
0.92
%
IndexRUT P/E32.29 EPS (ttm)8.82 Insider Own6.37% Shs Outstand16.98M Perf Week2.30%
Market Cap4.84B Forward P/E25.30 EPS next Y11.26 Insider Trans-4.07% Shs Float15.77M Perf Month14.14%
Enterprise Value5.44B PEG3.08 EPS next Q2.51 Inst Own114.81% Short Float12.10% Perf Quarter27.04%
Income152.26M P/S2.76 EPS this Y10.42% Inst Trans-3.66% Short Ratio10.77 Perf Half Y27.44%
Sales1.75B P/B5.11 EPS next Y8.93% ROA6.90% Short Interest1.91M Perf YTD70.14%
Book/sh55.72 P/C38.87 EPS next 5Y10.49% ROE17.58% 52W High285.00 -0.05% Perf Year108.77%
Cash/sh7.33 P/FCF43.56 EPS past 3/5Y10.51% 16.58% ROIC10.86% 52W Low146.32 94.68% Perf 3Y240.46%
Dividend Est.- EV/EBITDA19.55 Sales past 3/5Y13.13% 8.00% Gross Margin31.16% Volatility3.81% 3.94% Perf 5Y254.83%
Dividend TTM- EV/Sales3.10 EPS Y/Y TTM15.70% Oper. Margin13.44% ATR (14)10.33 Perf 10Y230.54%
Dividend Ex-Date- Quick Ratio1.29 Sales Y/Y TTM9.37% Profit Margin8.68% RSI (14)69.20 Recom1.33
Dividend Gr. 3/5Y- - Current Ratio1.87 EPS Q/Q11.86% SMA2010.05% Beta1.33 Target Price290.83
Payout0.00% Debt/Eq0.77 Sales Q/Q11.81% SMA5015.39% Rel Volume1.40 Prev Close282.27
Employees7337 LT Debt/Eq0.48 EarningsOct 30 AMC SMA20029.13% Avg Volume177.20K Price284.86
IPOOct 02, 1997 Option/ShortYes / Yes EPS/Sales Surpr.3.09% 3.41% Trades Volume245,190 Change0.92%
Date Action Analyst Rating Change Price Target Change
Feb-21-25Initiated JP Morgan Neutral $225
Jan-24-25Reiterated B. Riley Securities Buy $180 → $221
Sep-30-24Initiated BofA Securities Buy $175
Sep-18-24Initiated Wells Fargo Overweight $170
Jul-27-21Initiated Imperial Capital Outperform $140
Dec-10-20Initiated Oppenheimer Outperform $110
Nov-13-20Initiated Berenberg Buy $103
Aug-24-18Reiterated B. Riley FBR Buy $81 → $92.50
Jun-21-18Downgrade Sidoti Buy → Neutral
Feb-02-18Downgrade Jefferies Buy → Hold
Nov-06-25 12:37AM
Nov-03-25 12:00PM
Oct-31-25 01:00PM
08:46AM
Oct-30-25 11:01PM
06:30PM Loading…
06:30PM
06:05PM
05:07PM
05:02PM
04:02PM
Oct-29-25 05:25PM
09:33AM
Oct-28-25 11:08PM
Oct-23-25 08:30AM
Oct-22-25 02:25PM
11:40AM Loading…
Oct-17-25 11:40AM
Oct-16-25 10:00AM
12:00AM
Oct-02-25 08:30AM
Oct-01-25 11:40AM
Sep-30-25 08:30AM
Sep-29-25 08:30AM
Sep-25-25 11:34PM
08:30AM
Sep-15-25 11:40AM
12:39AM
Sep-10-25 12:01PM
Sep-09-25 04:15PM
08:30AM
Aug-28-25 01:31AM
03:09AM Loading…
Aug-22-25 03:09AM
01:30AM
Aug-21-25 02:45PM
10:00AM
09:40AM
09:07AM
08:43AM
08:40AM
08:30AM
06:35AM
05:38AM
Aug-20-25 09:17AM
Aug-19-25 11:00PM
06:20PM
Aug-18-25 05:25PM
09:15AM
Aug-14-25 08:30AM
Aug-07-25 07:10PM
Aug-06-25 07:30PM
Jul-30-25 05:55PM
Jul-29-25 12:10PM
Jul-27-25 11:32PM
Jul-23-25 11:40AM
Jul-14-25 12:09AM
Jul-10-25 08:30AM
Jul-07-25 08:30AM
Jul-03-25 08:30AM
Jul-02-25 08:30AM
Jun-30-25 08:30AM
Jun-26-25 03:58AM
Jun-25-25 07:49PM
Jun-24-25 08:30AM
Jun-18-25 12:32PM
Jun-16-25 11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
Jun-09-25 08:30AM
May-29-25 11:40AM
08:30AM
May-21-25 04:46PM
May-20-25 08:30AM
May-15-25 04:01PM
08:30AM
May-12-25 11:40AM
08:30AM
May-07-25 08:40AM
08:30AM
May-05-25 12:00PM
12:00PM
May-02-25 02:35PM
03:23AM
03:14AM
May-01-25 04:05PM
10:00AM
09:45AM
08:39AM
08:30AM
Apr-29-25 08:30AM
Apr-23-25 11:40AM
Apr-21-25 09:00PM
08:30AM
Apr-15-25 08:30AM
Apr-14-25 04:45AM
Apr-08-25 07:00PM
OSI Systems, Inc. engages in the design and manufacture of specialized electronic systems and components for critical applications. It operates through the following segments: Security, Optoelectronics and Manufacturing, Healthcare, and Corporate and Eliminations. The Security segment includes security and inspection systems, and turnkey security screening solutions. The Optoelectronics and Manufacturing segment refers to electronic components and electronic manufacturing services. The Healthcare segment focuses on the provision of patient monitoring, cardiology and remote monitoring, connected care systems, and associated accessories. The Corporate and Eliminations segment represents the executive compensation and certain other general and administrative expenses. The company was founded by Deepak Chopra in May 1987 and is headquartered in Hawthorne, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morben Paul KeithPRES., OPTOELECTRONICS DIVNov 07 '25Sale279.10416116,1068,540Nov 07 09:50 PM
HAWKINS JAMES BDirectorNov 07 '25Sale283.151,500424,7255,036Nov 07 09:50 PM
PAUL MORBENOfficerNov 07 '25Proposed Sale279.10416116,106Nov 07 04:28 PM
JAMES HAWKINSDirectorNov 07 '25Proposed Sale283.151,500424,719Nov 07 04:26 PM
CHOPRA DEEPAKEXECUTIVE CHAIRMANOct 01 '25Sale245.8020,0004,916,000312,969Oct 02 09:50 PM
CHOPRA FAMILY TRUST U/A DTD12/DirectorOct 01 '25Proposed Sale249.2420,0004,984,800Oct 01 04:35 PM
Ballhaus William Francis JRDirectorSep 12 '25Sale237.84562133,66625,600Sep 15 04:00 PM
BALLHAUS TRUSTDirectorSep 12 '25Proposed Sale237.84562133,664Sep 12 04:18 PM
Morben Paul KeithPRES., OPTOELECTRONICS DIVSep 04 '25Sale236.761,671395,6268,749Sep 05 08:00 PM
PAUL MORBENOfficerSep 04 '25Proposed Sale236.761,671395,626Sep 04 04:18 PM
LUSKIN MEYER/DirectorJun 12 '25Sale237.151,000237,15011,214Jun 13 06:25 PM
LUSKIN MEYER/DirectorJun 12 '25Proposed Sale236.681,000236,680Jun 12 06:30 PM
Ballhaus William Francis JRDirectorMay 21 '25Sale228.88750171,66024,055May 22 05:13 PM
BALLHAUS TRUSTDirectorMay 21 '25Proposed Sale228.88750171,660May 21 04:13 PM
EDRICK ALAN IEVP & CFOMay 13 '25Sale229.0020,0004,580,000284,953May 15 06:00 PM
ALAN I EDRICKOfficerMay 13 '25Proposed Sale229.0020,0004,580,000May 13 04:22 PM
Grindstaff GlennCHIEF HUMAN RESOURCES OFFICERMay 08 '25Sale224.89688154,7248,354May 09 08:25 PM
GLENN GRINDSTAFFOfficerMay 08 '25Proposed Sale224.89688154,724May 08 04:02 PM
Ballhaus William Francis JRDirectorMay 06 '25Sale219.77933205,04524,805May 07 04:10 PM
CHOPRA DEEPAKEXECUTIVE CHAIRMANMay 05 '25Sale221.7920,0004,435,800339,478May 07 04:10 PM
CHOPRA DEEPAKEXECUTIVE CHAIRMANMay 06 '25Sale220.115,0001,100,5500May 07 04:10 PM
BALLHAUS TRUSTDirectorMay 06 '25Proposed Sale219.78933205,051May 06 04:09 PM
DEEPAK CHOPRA TTEETHE DEEPIKA OfficerMay 06 '25Proposed Sale220.115,0001,100,541May 06 04:04 PM
CHOPRA FAMILY TRUST U/A DTD 12OfficerMay 05 '25Proposed Sale224.8620,0004,497,200May 05 04:56 PM
CHOPRA DEEPAKEXECUTIVE CHAIRMANFeb 04 '25Sale198.2620,0003,965,200364,478Feb 05 02:42 PM
CHOPRA DEEPAKEXECUTIVE CHAIRMANFeb 03 '25Sale193.5520,0003,871,000384,478Feb 05 02:42 PM
DEEPAK CHOPRAOfficerFeb 04 '25Proposed Sale198.2620,0003,965,210Feb 04 04:36 PM
CHOPRA FAMILY TRUST U/A DTD 12OfficerFeb 03 '25Proposed Sale196.4420,0003,928,800Feb 03 04:18 PM
Morben Paul KeithPRES., OSI ELECTRONICSJan 30 '25Sale199.3615530,90110,077Jan 31 10:55 AM
PAUL MORBENOfficerJan 30 '25Proposed Sale199.3615530,901Jan 30 04:01 PM
CHIZEVER GERALD MDirectorJan 27 '25Sale195.832,701528,9375,000Jan 27 05:28 PM
CHIZEVER GERALD MDirectorJan 27 '25Proposed Sale195.832,701528,940Jan 27 01:31 PM
EDRICK ALAN IEVP & CFODec 13 '24Sale188.007,6461,437,448304,798Dec 13 05:40 PM
EDRICK ALAN IEVP & CFODec 12 '24Sale188.422,354443,541312,444Dec 13 05:40 PM
CHOPRA DEEPAKPRESIDENT AND CEODec 12 '24Sale187.6620,0003,753,200404,323Dec 13 05:31 PM
ALIABADI MANOOCHER MPRES., OPTOELECTRONICS DIVDec 13 '24Sale180.022,509451,67078,094Dec 13 05:29 PM
MANOOCHER MANSOURI-ALIABADIOfficerDec 13 '24Proposed Sale180.022,509451,676Dec 13 04:41 PM
ALAN EDRICKOfficerDec 13 '24Proposed Sale188.007,6461,437,448Dec 13 04:23 PM
DEEPAK CHOPRAOfficerDec 12 '24Proposed Sale187.6620,0003,753,280Dec 12 05:07 PM
HAWKINS JAMES BDirectorDec 10 '24Sale182.622,000365,2406,396Dec 12 04:43 PM
ALAN EDRICKOfficerDec 12 '24Proposed Sale188.422,354443,547Dec 12 04:43 PM
Ballhaus William Francis JRDirectorDec 10 '24Sale181.63675122,60026,516Dec 12 04:42 PM
BALLHAUS TRUSTDirectorDec 10 '24Proposed Sale181.63675122,598Dec 10 04:36 PM
JAMES HAWKINSDirectorDec 10 '24Proposed Sale182.622,000365,249Dec 10 04:05 PM
ALIABADI MANOOCHER MPRES., OPTOELECTRONICS DIVDec 04 '24Sale180.391,728311,71480,603Dec 06 08:09 AM
MANOOCHER MANSOURI-ALIABADIOfficerDec 04 '24Proposed Sale180.391,728311,713Dec 04 05:00 PM
CHOPRA DEEPAKPRESIDENT AND CEONov 12 '24Sale153.8720,0003,077,400424,323Nov 13 06:00 PM
CHOPRA DEEPAKPRESIDENT AND CEONov 11 '24Sale153.4215,0002,301,2500Nov 13 06:00 PM
CHOPRA 2012 IRREVOCABLE TRUSTspouse Nov 11 '24Proposed Sale153.475,000767,326Nov 12 08:49 AM
THE DEEPIKA CHOPRA TRUSTOfficerNov 11 '24Proposed Sale153.3910,0001,533,882Nov 12 08:47 AM
Last Close
Nov 07  •  04:00PM ET
0.5431
Dollar change
-0.0027
Percentage change
-0.49
%
HBIO Harvard Bioscience Inc daily Stock Chart
Index- P/E- EPS (ttm)-1.22 Insider Own14.50% Shs Outstand44.58M Perf Week5.13%
Market Cap24.21M Forward P/E5.72 EPS next Y0.10 Insider Trans0.00% Shs Float38.11M Perf Month22.90%
Enterprise Value60.17M PEG- EPS next Q0.04 Inst Own42.64% Short Float1.52% Perf Quarter13.38%
Income-53.84M P/S0.28 EPS this Y0.00% Inst Trans-15.90% Short Ratio0.09 Perf Half Y72.41%
Sales87.37M P/B1.72 EPS next Y216.67% ROA-51.46% Short Interest0.58M Perf YTD-74.26%
Book/sh0.32 P/C3.55 EPS next 5Y- ROE-135.62% 52W High2.61 -79.19% Perf Year-77.28%
Cash/sh0.15 P/FCF3.59 EPS past 3/5Y-242.36% -18.10% ROIC-251.57% 52W Low0.28 93.07% Perf 3Y-79.74%
Dividend Est.- EV/EBITDA12.88 Sales past 3/5Y-7.49% -4.12% Gross Margin51.87% Volatility18.05% 13.34% Perf 5Y-84.30%
Dividend TTM- EV/Sales0.69 EPS Y/Y TTM-271.93% Oper. Margin-1.83% ATR (14)0.07 Perf 10Y-81.53%
Dividend Ex-Date- Quick Ratio0.41 Sales Y/Y TTM-10.60% Profit Margin-61.62% RSI (14)57.07 Recom2.00
Dividend Gr. 3/5Y- - Current Ratio0.81 EPS Q/Q74.93% SMA2016.46% Beta1.55 Target Price2.00
Payout- Debt/Eq3.04 Sales Q/Q-6.28% SMA5018.15% Rel Volume0.34 Prev Close0.55
Employees355 LT Debt/Eq0.52 EarningsNov 06 BMO SMA200-7.80% Avg Volume6.19M Price0.54
IPODec 07, 2000 Option/ShortYes / Yes EPS/Sales Surpr.-100.00% 2.96% Trades Volume2,101,750 Change-0.49%
Date Action Analyst Rating Change Price Target Change
Apr-09-25Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Mar-10-23Upgrade The Benchmark Company Speculative Buy → Buy $3 → $4
Jan-07-21Upgrade The Benchmark Company Speculative Buy → Buy
Dec-09-20Initiated Northland Capital Outperform $6
Nov-10-20Initiated KeyBanc Capital Markets Overweight $6
Jul-08-19Downgrade Janney Buy → Neutral $2
Jan-24-18Reiterated Janney Buy $5 → $8
Jan-23-18Reiterated The Benchmark Company Buy $6 → $10
Nov-17-16Initiated Singular Research Buy $5.50
Jul-28-15Initiated The Benchmark Company Buy $8
Nov-06-25 02:05PM
07:31AM
07:00AM
Oct-30-25 08:00AM
Sep-16-25 07:00AM
07:00AM Loading…
Sep-09-25 07:00AM
Aug-12-25 03:02AM
Aug-11-25 07:20AM
07:00AM
Aug-08-25 09:33AM
Aug-04-25 04:30PM
Jul-17-25 07:00AM
Jun-02-25 04:57PM
May-14-25 09:14AM
May-13-25 03:03AM
11:28PM Loading…
May-12-25 11:28PM
07:13AM
07:00AM
May-09-25 09:52AM
May-05-25 04:45PM
Apr-10-25 04:45PM
Mar-13-25 01:18AM
Mar-12-25 04:00PM
07:21AM
Feb-24-25 04:45PM
11:00AM
Jan-21-25 09:00AM
Jan-13-25 05:52PM
Nov-08-24 02:08AM
Nov-07-24 07:12AM
07:00AM Loading…
07:00AM
Nov-06-24 07:50AM
Oct-29-24 05:00PM
Oct-09-24 05:43PM
Oct-03-24 08:00AM
Sep-18-24 07:30AM
Sep-17-24 08:00AM
Sep-05-24 04:05PM
Aug-08-24 08:37AM
08:30AM
Aug-02-24 08:00AM
Jun-06-24 04:05PM
May-23-24 04:05PM
May-16-24 04:05PM
May-08-24 10:14AM
03:03AM
May-07-24 11:56AM
08:41AM
08:15AM
07:13AM
07:00AM
Apr-29-24 08:45AM
Apr-09-24 09:00AM
Mar-12-24 10:30AM
Mar-11-24 08:00AM
Mar-08-24 10:48AM
Mar-07-24 10:51PM
01:56PM
12:53PM
07:32AM
07:00AM
Mar-06-24 08:30AM
Feb-27-24 05:10PM
Nov-20-23 04:40PM
Nov-09-23 04:30PM
02:28PM
Nov-07-23 09:58PM
08:00AM
07:28AM
07:00AM
Nov-06-23 04:30PM
Oct-30-23 09:00AM
Sep-18-23 08:57AM
Aug-15-23 10:20AM
Aug-08-23 09:43PM
09:15AM
08:05AM
07:18AM
Aug-03-23 06:30PM
Jul-27-23 06:36PM
Jun-22-23 07:55AM
Jun-21-23 08:50AM
Jun-20-23 08:01AM
Jun-13-23 12:21PM
May-25-23 08:50AM
May-24-23 08:26AM
May-23-23 10:17AM
May-09-23 09:40AM
08:50AM
07:15AM
May-02-23 05:01PM
08:35AM
Apr-27-23 06:14PM
Apr-26-23 12:02AM
Apr-25-23 08:41AM
08:01AM
Apr-18-23 05:10PM
Apr-17-23 04:45PM
Apr-11-23 08:28AM
Mar-28-23 06:14AM
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.